Widely used:Recently Viewed
Clear All
Today’s Range
52 Week Range
Liquidity
Market cap
$395 Mln
P/E Ratio
--
P/B Ratio
340.53
Industry P/E
--
Debt to Equity
--
ROE
-1.66 %
ROCE
-150.21 %
Div. Yield
0 %
Book Value
--
EPS
-0.12
CFO
$-625.28 Mln
EBITDA
$-653.99 Mln
Net Profit
$-799.08 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Senseonics Holdings (SENS)
| 15.84 | 2.23 | -30.71 | 40.31 | -29.36 | -1.98 | -- |
|
BSE Sensex
| 0.39 | 6.40 | 1.96 | 7.69 | 10.43 | 20.75 | 10.61 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Senseonics Holdings (SENS)
| -8.11 | -44.66 | -61.42 | 206.19 | -4.80 | -64.63 | -2.62 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 | 25.27 | 9.57 | 20.86 | -9.70 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 15.17 | 10,493.90 | 14.81 | 12.69 | |
| 71.50 | 9,951.16 | 96.47 | 2.52 | |
| 151.59 | 8,216.59 | -- | -25.23 | |
| 277.11 | 10,486.34 | 777.89 | 1.2 |
Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's... products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company was founded in 1996 and is headquartered in Germantown, Maryland. Address: 20451 Seneca Meadows Parkway, Germantown, MD, United States, 20876-7005 Read more
President, CEO & Director
Dr. Timothy T. Goodnow Ph.D.
General Counsel & Corporate Development Advisor
Mr. Kenneth L. Horton J.D.
Headquarters
Germantown, MD
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Senseonics Holdings Inc (SENS) stood at -- as on 31-Dec-24
The share price of Senseonics Holdings Inc (SENS) is $0.61 (NYSE) as of 17-Apr-2025 12:35 EDT. Senseonics Holdings Inc (SENS) has given a return of -29.36% in the last 3 years.
Senseonics Holdings Inc (SENS) has a market capitalisation of $ 395 Mln as on 16-Apr-2025. As per Value Research classification, it is a Small Cap company.
Since, TTM earnings of Senseonics Holdings Inc (SENS) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Senseonics Holdings Inc (SENS) and enter the required number of quantities and click on buy to purchase the shares of Senseonics Holdings Inc (SENS).
Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company was founded in 1996 and is headquartered in Germantown, Maryland. Address: 20451 Seneca Meadows Parkway, Germantown, MD, United States, 20876-7005
The CEO & director of Dr. Timothy T. Goodnow Ph.D.. is Senseonics Holdings Inc (SENS), and CFO & Sr. VP is Mr. Kenneth L. Horton J.D..
There is no promoter pledging in Senseonics Holdings Inc (SENS).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,083
|
|
|
1,061
|
|
|
1,022
|
|
|
889
|
| Senseonics Holdings Inc. (SENS) | Ratios |
|---|---|
|
Return on equity(%)
|
-276.34
|
|
Operating margin(%)
|
--
|
|
Net Margin(%)
|
-349.84
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Senseonics Holdings Inc (SENS) was $0 Mln.
$0.01
(
